Literature DB >> 202222

New insights into cholesterol dynamics.

T A Miettinen.   

Abstract

Kinetic aspects of cholesterol dynamics are described, with flux from the gut, to the liver, to the tissues, and back to the liver and gut, with a discussion of modifying mechanisms, synthesis, and transport. Overproduction of cholesterol, and bile acid and cholesterol malabsorption, are related to clinical problems.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 202222     DOI： 10.1001/archsurg.1978.01370130047007

Source DB:  PubMed          Journal:  Arch Surg        ISSN： 0004-0010


  7 in total

1.  Ileal bypass for hyperlipidemia.

Authors:  H Buchwald; L Fitch; R L Varco
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

2.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

Authors:  D W Bilheimer; N J Stone; S M Grundy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

3.  Elevated cholesterol and bile acid synthesis in an adult patient with homozygous familial hypercholesterolemia. Reduction by a high glucose diet.

Authors:  P W Stacpoole; S M Grundy; L L Swift; H L Greene; A E Slonim; I M Burr
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

4.  [Causes, shape and chemistry of gallstones].

Authors:  F Bolck; G Machnik
Journal:  Naturwissenschaften       Date:  1979-01

5.  Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.

Authors:  T A Miettinen
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  Enhanced synthesis of cholesterol and its precursors in jejunal mucosa in coeliac disease.

Authors:  M Vuoristo; T A Miettinen
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

7.  Elevated cholesterol and bile acid synthesis in a young patient with homozygous familial hypercholesterolemia.

Authors:  K B Schwarz; J Witztum; G Schonfeld; S M Grundy; W E Connor
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.